Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.05 USD | -0.18% | +2.03% | -45.54% |
Apr. 30 | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 17.19 | 24.13 | 22.84 |
Spread/Res. | -0.81% | -29.34% | -25.35% |
Spread/Supp. | +4.54% | +4.54% | +2.03% |
Support | 16.31 | 16.31 | 16.71 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ACAD Stock
- Charts ACADIA Pharmaceuticals Inc.